Abstract
Effect of Diabetes on the Pharmacokinetic Profile of Fluoroquinolones Faith Onyinye Okpana, Peter Achunike Akah Abstract Fluoroquinolones are broad spectrum antibiotics used clinically to treat bacterial infectious diseases. They are among the commonly and widely prescribed antibiotics. Reports have linked the use of fluoroquinolones to significant dysglycemia. This work was designed to investigate the pharmacokinetic profile of ciprofloxacin, levofloxacin and moxifloxacin in diabetic rats. Methods. Streptozotocin-induced diabetic rats were treated orally with the fluoroquinolones for 7 days, Blood samples were collected from the retro orbital plexus for the estimation of serum concentration, area under the curve, mean retention time, half lives, volume of distribution and other pharmacokinetic indices. Results: The result revealed increase in the values of maximum serum concentration (Cmax), area under the curve (AUC), area under the moment curve (AUMC), mean resident time (MRT), half life (t1/2), volume of distribution (Vd) and decreased clearance rate (Cl) compared with the values in non diabetic rats. The effects were more on moxifloxacin and least on ciprofloxacin. Conclusion: Diabetes state significantly (p < 0.05) elevated the pharmacokinetic indices of fluoroquinolones. Full Text: PDF DOI: 10.15640/ijmp.v6n2a4
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
